Descriptive statistics
. | Treated aviremic . | Untreated viremic . | Treated viremic . | Primary infection . | Nonprogressive infection . | HIV-1-negative controls . |
|---|---|---|---|---|---|---|
| No. | 11 | 14 | 9 | 10 | 11 | 14 |
| Sex, no. | ||||||
| M | 10 | 10 | 8 | 9 | 10 | 9 |
| F | 1 | 4 | 1 | 1 | 1 | 5 |
| CD4, mean cells per mL (range) | 543 (230-786) | 390 (67-503) | 247 (72-429) | 724 (377-1 234) | 623 (318-880) | NA |
| Viral load, mean copies of RNA per mL (range) | < 50 | 67 800 (11 690-133 187) | 74 000 (407-198 000) | 166 750 (28 500-750 000) | 928 (< 50-4 110) | NA |
. | Treated aviremic . | Untreated viremic . | Treated viremic . | Primary infection . | Nonprogressive infection . | HIV-1-negative controls . |
|---|---|---|---|---|---|---|
| No. | 11 | 14 | 9 | 10 | 11 | 14 |
| Sex, no. | ||||||
| M | 10 | 10 | 8 | 9 | 10 | 9 |
| F | 1 | 4 | 1 | 1 | 1 | 5 |
| CD4, mean cells per mL (range) | 543 (230-786) | 390 (67-503) | 247 (72-429) | 724 (377-1 234) | 623 (318-880) | NA |
| Viral load, mean copies of RNA per mL (range) | < 50 | 67 800 (11 690-133 187) | 74 000 (407-198 000) | 166 750 (28 500-750 000) | 928 (< 50-4 110) | NA |
NA indicates not applicable.